1. Blinatumomab as first salvage versus second or later salvage in adults with relapsed/refractory B‐cell precursor acute lymphoblastic leukemia: Results of a pooled analysis. (18th March 2021) Authors: Topp, Max S.; Stein, Anthony S.; Gökbuget, Nicola; Horst, Heinz‐August; Boissel, Nicolas; Martinelli, Giovanni; Kantarjian, Hagop; Brüggemann, Monika; Chen, Yuqi; Zugmaier, Gerhard Journal: Cancer medicine Issue: Volume 10:Number 8(2021) Page Start: 2601 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Blinatumomab treatment of older adults with relapsed/refractory B‐precursor acute lymphoblastic leukemia: Results from 2 phase 2 studies. Issue 14 (3rd May 2016) Authors: Kantarjian, Hagop M.; Stein, Anthony S.; Bargou, Ralf C.; Grande Garcia, Carlos; Larson, Richard A.; Stelljes, Matthias; Gökbuget, Nicola; Zugmaier, Gerhard; Benjamin, Jonathan E.; Zhang, Alicia; Jia, Catherine; Topp, Max S. Journal: Cancer Issue: Volume 122:Issue 14(2016) Page Start: 2178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Blinatumomab versus chemotherapy in first salvage or in later salvage for B-cell precursor acute lymphoblastic leukemia. Issue 9 (29th July 2019) Authors: Dombret, Hervé; Topp, Max S.; Schuh, Andre C.; Wei, Andrew H.; Durrant, Simon; Bacon, Christopher Larry; Tran, Qui; Zimmerman, Zachary; Kantarjian, Hagop Journal: Leukemia & lymphoma Issue: Volume 60:Issue 9(2019) Page Start: 2214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Combined PI3K/Akt and Hsp90 targeting synergistically suppresses essential functions of alloreactive T cells and increases Tregs. Issue 6 (11th August 2015) Authors: Berges, Carsten; Bedke, Tanja; Stuehler, Claudia; Khanna, Nina; Zehnter, Sarah; Kruhm, Michaela; Winter, Nadine; Bargou, Ralf C.; Topp, Max S.; Einsele, Hermann; Chatterjee, Manik Journal: Journal of leukocyte biology Issue: Volume 98:Issue 6(2015) Page Start: 1091 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia. Issue 11 (18th September 2020) Authors: Gökbuget, Nicola; Zugmaier, Gerhard; Dombret, Hervé; Stein, Anthony; Bonifacio, Massimiliano; Graux, Carlos; Faul, Christoph; Brüggemann, Monika; Taylor, Kate; Mergen, Noemi; Reichle, Albrecht; Horst, Heinz-August; Havelange, Violaine; Topp, Max S.; Bargou, Ralf C. Journal: Leukemia & lymphoma Issue: Volume 61:Issue 11(2020) Page Start: 2665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma. (29th September 2021) Authors: Topp, Max S.; van Meerten, Tom; Houot, Roch; Minnema, Monique C.; Bouabdallah, Krimo; Lugtenburg, Pieternella J.; Thieblemont, Catherine; Wermke, Martin; Song, Kevin W.; Avivi, Irit; Kuruvilla, John; Dührsen, Ulrich; Zheng, Yan; Vardhanabhuti, Saran; Dong, Jinghui; Bot, Adrian; Rossi, John M.; Pl... Journal: British journal of haematology Issue: Volume 195:Number 3(2021) Page Start: 388 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Hsp90 inhibition ameliorates CD4+ T cell‐mediated acute Graft versus Host disease in mice. Issue 4 (10th October 2016) Authors: Berges, Carsten; Kerkau, Thomas; Werner, Sandra; Wolf, Nelli; Winter, Nadine; Hünig, Thomas; Einsele, Hermann; Topp, Max S.; Beyersdorf, Niklas Journal: Immunity, inflammation and disease Issue: Volume 4:Issue 4(2016) Page Start: 463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Long‐term survival of patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab. Issue 4 (3rd November 2020) Authors: Topp, Max S.; Gökbuget, Nicola; Zugmaier, Gerhard; Stein, Anthony S.; Dombret, Hervé; Chen, Yuqi; Ribera, Josep‐Maria; Bargou, Ralf C.; Horst, Heinz‐August; Kantarjian, Hagop M. Journal: Cancer Issue: Volume 127:Issue 4(2021) Page Start: 554 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Outcome of patients with relapsed/refractory acute lymphoblastic leukemia after blinatumomab failure: No change in the level of CD19 expression. Issue 3 (23rd December 2017) Authors: Jabbour, Elias; Düll, Johannes; Yilmaz, Musa; Khoury, Joseph D.; Ravandi, Farhad; Jain, Nitin; Einsele, Hermann; Garcia‐Manero, Guillermo; Konopleva, Marina; Short, Nicholas J.; Thompson, Philip A.; Wierda, William; Daver, Naval; Cortes, Jorge; O'brien, Susan; Kantarjian, Hagop; Topp, Max S. Journal: American journal of hematology Issue: Volume 93:Issue 3(2018:Mar.) Page Start: 371 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Phase II study of fixed‐duration single‐agent ibrutinib in relapsed nodular lymphocyte‐predominant Hodgkin lymphoma: A report from the German Hodgkin Study Group. Issue 4 (24th March 2022) Authors: Eichenauer, Dennis A.; Bühnen, Ina; Plütschow, Annette; Kobe, Carsten; Dietlein, Markus; Wendtner, Clemens‐Martin; Thorspecken, Sven; Topp, Max S.; Mauser, Mareike; von Tresckow, Bastian; Fuchs, Michael; Borchmann, Peter; Engert, Andreas Journal: Hematological oncology Issue: Volume 40:Issue 4(2022) Page Start: 801 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗